T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
Global Payments
GPN
|
+$2B |
| 3 |
NextEra Energy
NEE
|
+$1.82B |
| 4 |
Salesforce
CRM
|
+$1.51B |
| 5 |
Boeing
BA
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.43B |
| 5 |
Elevance Health
ELV
|
+$1.39B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
UFP Technologies
UFPT
$2.51B
| $210K | ﹤0.01% |
+5,439
| New | +$224K |
|
2377
Alector
ALEC
$230M
| $209K | ﹤0.01% |
+14,485
| New | +$261K |
|
|
CYBE
2378
DELISTED
Cyberoptics Corp
CYBE
| $209K | ﹤0.01% |
14,600
| – | – |
|
|
DTV
2379
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
| $203K | ﹤0.01% |
3,500
-553,005
| -99% | -$31.4M |
|
|
PRGX
2380
DELISTED
PRGX Global, Inc.
PRGX
| $202K | ﹤0.01% |
39,287
+104
| +0.3% | +$601 |
|
|
CLVS
2381
DELISTED
Clovis Oncology, Inc.
CLVS
| $201K | ﹤0.01% |
51,141
+21,416
| +72% | +$173K |
|
|
INAP
2382
DELISTED
Internap Corporation
INAP
| $200K | ﹤0.01% |
77,675
| – | – |
|
2383
AudioCodes
AUDC
$254M
| $199K | ﹤0.01% |
+10,500
| New | +$189K |
|
2384
W&T Offshore
WTI
$543M
| $198K | ﹤0.01% |
45,397
+541
| +1% | +$2.47K |
|
|
CALA
2385
DELISTED
Calithera Biosciences, Inc
CALA
| $193K | ﹤0.01% |
3,125
+309
| +11% | +$24.7K |
|
2386
Amkor Technology
AMKR
$14.5B
| $192K | ﹤0.01% |
21,133
+1,017
| +5% | +$8.72K |
|
2387
Commercial Vehicle Group
CVGI
$130M
| $191K | ﹤0.01% |
26,510
+206
| +0.8% | +$1.51K |
|
2388
First US Bancshares
FUSB
$92.3M
| $188K | ﹤0.01% |
20,950
| – | – |
|
2389
Manitowoc
MTW
$736M
| $187K | ﹤0.01% |
14,965
+260
| +2% | +$3.93K |
|
|
RRD
2390
DELISTED
RR Donnelley & Sons Co.
RRD
| $187K | ﹤0.01% |
49,649
+394
| +0.8% | +$937 |
|
|
HPR
2391
DELISTED
HighPoint Resources Corporation
HPR
| $187K | ﹤0.01% |
2,353
+13
| +0.6% | +$904 |
|
2392
Lexicon Pharmaceuticals
LXRX
$1.05B
| $186K | ﹤0.01% |
61,830
+188
| +0.3% | +$582 |
|
2393
Gogo Inc
GOGO
$375M
| $184K | ﹤0.01% |
30,448
+708
| +2% | +$3.34K |
|
2394
Titan Machinery
TITN
$422M
| $184K | ﹤0.01% |
12,843
+87
| +0.7% | +$1.55K |
|
2395
Cartesian Therapeutics
RNAC
$267M
| $182K | ﹤0.01% |
3,475
-2,721
| -44% | -$145K |
|
|
ACH
2396
Accendra Health
ACH
$85.4M
| $181K | ﹤0.01% |
31,238
+313
| +1% | +$1.4K |
|
2397
Arlo Technologies
ARLO
$1.52B
| $179K | ﹤0.01% |
52,445
+409
| +0.8% | +$1.49K |
|
2398
Bassett Furniture
BSET
$173M
| $175K | ﹤0.01% |
11,433
+65
| +0.6% | +$858 |
|
|
XEC
2399
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $168K | ﹤0.01% |
+3,500
| New | +$166K |
|
2400
Inseego
INSG
$77.7M
| $167K | ﹤0.01% |
3,484
+20
| +0.6% | +$930 |
|
Similar funds
T. Rowe Price Associates's Q3 2019 Portfolio in Review
As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
- T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
- T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
- T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
- T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
- T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.
Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.